Christopher J. Pirozzi

1.9k total citations · 1 hit paper
25 papers, 689 citations indexed

About

Christopher J. Pirozzi is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Christopher J. Pirozzi has authored 25 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Christopher J. Pirozzi's work include Glioma Diagnosis and Treatment (11 papers), Epigenetics and DNA Methylation (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Christopher J. Pirozzi is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Epigenetics and DNA Methylation (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Christopher J. Pirozzi collaborates with scholars based in United States, China and United Kingdom. Christopher J. Pirozzi's co-authors include Hai Yan, Changcun Guo, Darell D. Bigner, Giselle Y. López, Lee H. Chen, Roger E. McLendon, Yiping He, Paula K. Greer, Yiping He and Landon J. Hansen and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Christopher J. Pirozzi

20 papers receiving 684 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The implications of IDH mutations for cancer development and therapy

2021 226 citations Christopher J. Pirozzi, Hai Yan Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Pirozzi United States	12	374	255	246	105	101	25	689
Matthew S. Waitkus United States	13	429 1.1×	337 1.3×	287 1.2×	79 0.8×	133 1.3×	25	776
I‐Mei Siu United States	16	494 1.3×	292 1.1×	190 0.8×	121 1.2×	160 1.6×	22	823
Myriam Maoz Israel	17	428 1.1×	156 0.6×	298 1.2×	77 0.7×	180 1.8×	30	902
Koji Oka Japan	9	310 0.8×	351 1.4×	195 0.8×	138 1.3×	227 2.2×	23	727
Ewelina Stoczyńska-Fidelus Poland	14	331 0.9×	211 0.8×	157 0.6×	54 0.5×	167 1.7×	41	627
Alexandra Borodovsky United States	14	698 1.9×	312 1.2×	229 0.9×	79 0.8×	220 2.2×	26	1.0k
Ingrid Moen Norway	8	393 1.1×	263 1.0×	415 1.7×	139 1.3×	187 1.9×	16	934
Tina Zheng United States	4	305 0.8×	205 0.8×	159 0.6×	75 0.7×	158 1.6×	7	626
Carlos Clara Brazil	14	348 0.9×	274 1.1×	181 0.7×	69 0.7×	156 1.5×	38	619
Anna C. Navis Netherlands	16	370 1.0×	256 1.0×	236 1.0×	90 0.9×	129 1.3×	18	685

Countries citing papers authored by Christopher J. Pirozzi

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Pirozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Pirozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Pirozzi more than expected).

Fields of papers citing papers by Christopher J. Pirozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Pirozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Pirozzi. The network helps show where Christopher J. Pirozzi may publish in the future.

Co-authorship network of co-authors of Christopher J. Pirozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Pirozzi. A scholar is included among the top collaborators of Christopher J. Pirozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Pirozzi. Christopher J. Pirozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pirozzi, Christopher J., Bill H. Diplas, Roger E. McLendon, et al.. (2026). SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use alternative lengthening of telomeres. Neuro-Oncology.

Jin, Chen, David Moon, Hong Zhang, et al.. (2025). Resilience and Vulnerabilities of Tumor Cells under Purine Shortage Stress. Clinical Cancer Research. 31(20). 4345–4360.

Jiao, Meng, et al.. (2024). Targeting Catechol-O-Methyltransferase Induces Mitochondrial Dysfunction and Enhances the Efficacy of Radiotherapy in Glioma. Cancer Research. 84(21). 3640–3656. 5 indexed citations

Jin, Chen, Hailang Luo, Boyang Li, et al.. (2024). The CCL5/CCR5/SHP2 axis sustains Stat1 phosphorylation and activates NF-κB signaling promoting M1 macrophage polarization and exacerbating chronic prostatic inflammation. Cell Communication and Signaling. 22(1). 584–584. 8 indexed citations

Yang, Qing, et al.. (2024). Gene expression analysis suggests immunosuppressive roles of endolysosomes in glioblastoma. PLoS ONE. 19(3). e0299820–e0299820.

Diplas, Bill H., et al.. (2023). Abstract 3143: A bioinformatic pipeline for identifying change-of-metabolic-function cancer mutations. Cancer Research. 83(7_Supplement). 3143–3143. 1 indexed citations

Yang, Rui, Xiao Song, Bo Hu, et al.. (2023). Repurposing Clemastine to Target Glioblastoma Cell Stemness. Cancers. 15(18). 4619–4619.

Diplas, Bill H., et al.. (2023). Mining cancer genomes for change-of-metabolic-function mutations. Communications Biology. 6(1). 1143–1143.

Hansen, Landon J., Rui Yang, Wenzhe Wang, et al.. (2022). MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization. Scientific Reports. 12(1). 4183–4183. 22 indexed citations

10.

Xu, Cheng, Heng Liu, Christopher J. Pirozzi, et al.. (2021). TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist. Acta Neuropathologica Communications. 9(1). 178–178. 12 indexed citations

11.

Pirozzi, Christopher J. & Hai Yan. (2021). The implications of IDH mutations for cancer development and therapy. Nature Reviews Clinical Oncology. 18(10). 645–661. 226 indexed citations breakdown →

12.

Moure, Casey J., Bill H. Diplas, Lee H. Chen, et al.. (2019). CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP. Molecular Cancer Research. 17(10). 2042–2050. 17 indexed citations

13.

Liu, Yang, Austin B. Carpenter, Christopher J. Pirozzi, et al.. (2019). Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe. Nanotechnology. 30(27). 275101–275101. 19 indexed citations

14.

Pirozzi, Christopher J., et al.. (2018). Glioma Research in the era of medical big data. 4(4). 95. 2 indexed citations

15.

Pirozzi, Christopher J. & Hai Yan. (2018). Improved grading of IDH-mutated astrocytic gliomas. Nature Reviews Neurology. 14(7). 383–384. 2 indexed citations

16.

Yang, Rui, Lee H. Chen, Landon J. Hansen, et al.. (2017). Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation. Cancer Research. 77(22). 6097–6108. 33 indexed citations

17.

Pirozzi, Christopher J., Austin B. Carpenter, Matthew S. Waitkus, et al.. (2017). Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression. Molecular Cancer Research. 15(5). 507–520. 31 indexed citations

18.

Waitkus, Matthew S., Christopher J. Pirozzi, Casey J. Moure, et al.. (2017). Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities. Cancer Research. 78(1). 36–50. 33 indexed citations

19.

Jin, Genglin, Christopher J. Pirozzi, Lee H. Chen, et al.. (2012). Mutant IDH1 is required for IDH1 mutated tumor cell growth. Oncotarget. 3(8). 774–782. 31 indexed citations

20.

Guo, Changcun, Christopher J. Pirozzi, Giselle Y. López, & Hai Yan. (2011). Isocitrate dehydrogenase mutations in gliomas. Current Opinion in Neurology. 24(6). 648–652. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact